Press Releases

World's Poorest Children Among First to Receive New Life-Saving Pneumococcal Vaccines
Geneva, 23 March 2010
Pharmaceutical Firms and GAVI Alliance Agree to Provide Long-term Affordable Supply

Pneumococcal AMC receives four offers from vaccine manufacturers
Geneva, 12 October 2009
The AMC Secretariat is pleased to announce that four suppliers have made offers to supply vaccines under the Pneumococcal Advance Market Commitment.

Update: GAVI Partners Fulfil Promise to Fight Pneumococcal Disease
LECCE, Italy, 12 June 2009
The GAVI Alliance partners, the World Bank, WHO and UNICEF, and five national governments and the Bill & Melinda Gates Foundation today formally kicked-off the first-ever Advance Market Commitment (AMC) designed to accelerate access to vaccines against pneumococcal disease.

Update: GAVI Alliance welcomes World Bank decision on AMC initiative
6 April 2008
GAVI Alliance Chief Executive Officer Dr. Julian Lob-Levyt welcomes the April 3rd decision by the World Bank to provide a financial platform for the AMC.

Update: Target Product Profile (TPP) for the Pneumococcal AMC endorsed by the Independent Assessment Committee (IAC)
December 2008
The Target Product Profile (TPP) for the Pneumococcal Advanced Market Commitment (AMC) was developed by the World Health Organization at the request of the AMC Secretariat. On December 11, 2008 the Independent Assessment Committee (IAC) officially endorsed the TPP, making it the definitive guidelines for determining the characteristics of AMC-eligible pneumococcal conjugate vaccines.

Update from Donor Committee: Joint Donor Statement
July 2008
AMC donors welcome report recommending the terms on which a pilot AMC against pneumococcal disease will be offered to help developing countries buy new, more effective pneumococcal vaccines.

Update from Donor Committee: Pilot Advance Market Commitment for Pneumococcal Disease
June 2008
The leading cause of death among children under five, pneumococcal disease causes pneumonia, meningitis and sepsis.

Update from Donor Committee: Work is underway to determine the optimal terms for a pilot AMC.
May 2008
Pneumococcal diseases kill more than 1.6 million people worldwide each year, including at least 800,000 children. The most effective way to prevent these deaths is to ensure children have access to effective, safe and affordable vaccines.

AMC telebriefing: agenda, speaker bios, and instructions for listening to a recording of the call (mp3)
April 2008

Five nations and the Bill & Melinda Gates Foundation launch AMC for vaccines to combat deadly disease in poor nations
February 2007
Canada, Italy, Norway, Russia, the United Kingdom, and the Bill & Melinda Gates Foundation today committed US$1.5 billion to launch the first Advance Market Commitment (AMC) to help speed the development and availability of a new vaccine which is expected to save the lives of 5.4 million children by 2030.
[Italian] [French] [Spanish] [Russian] [German]

Norwegian Government to provide NOK 350 million for purchase of vaccines
February 2007
Norway's Minister of International Development Erik Solheim announces that the Norwegian Government will support Advanced Market Commitments for Vaccines (AMCs), a scheme that guarantees future public purchases of vaccines for developing countries.